Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer : vimarsana.com

ZUG, Switzerland, April 10, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bra...

Related Keywords

Switzerland , Morgan Conn , Berndt Modig , David Nassif , Amphastar Pharmaceuticals , Questcor Pharmaceuticals , Cypros Pharmaceuticals , University Of Virginia School Law , University Of Virginia , Chief Financial Officer , Chief Executive Officer , Chief Business , Board Member , Sio Gene Therapies , Sio Gene , Executive Vice President , Steadymed Therapeutics , United Therapeutics , Virginia School ,